Bank of Montreal
AMLX icon

Bank of Montreal’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bank of Montreal’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-138,525
Closed -$1.67M – 3749
2025
Q4 		$1.67M Sell
138,525
-5,227
-4% -$71K ﹤0.01% 1728
2025
Q3 		$1.95M Buy
143,752
+240
+0.2% +$2.26K ﹤0.01% 1666
2025
Q2 		$920K Hold
143,512
– – ﹤0.01% 1948
2025
Q1 		$508K Hold
143,512
– – ﹤0.01% 2186
2024
Q4 		$542K Hold
143,512
– – ﹤0.01% 2191
2024
Q3 		$442K Buy
143,512
+38,263
+36% +$86K ﹤0.01% 2506
2024
Q2 		$202K Buy
+105,249
New +$204K ﹤0.01% 2995
2023
Q3 		– Sell
-59,230
Closed -$1.42M – 3787
2023
Q2 		$1.42M Buy
+59,230
New +$1.6M ﹤0.01% 2001

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Bank of Montreal's AMLX Position: Q1 2026 in Review

Bank of Montreal sold out of Amylyx Pharmaceuticals (AMLX) in Q1 2026, closing a stake of 138,525 shares — an estimated $1.67M sold.

Bank of Montreal first reported a position in AMLX in Q2 2023 and held it in 8 quarters. The position peaked at $1.95M in Q3 2025. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Bank of Montreal reported no remaining Amylyx Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 138,525 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $1.67M.
  • Bank of Montreal first reported a position in Amylyx Pharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Bank of Montreal's Amylyx Pharmaceuticals position peaked at $1.95M in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.